February 16, 2026

Breaking the Biomarker Bottlenecks: Part 2

Industry leaders from AstraZeneca, Leica Biosystems, and Danaher share their insights on AI’s power to democratize access to precision medicine

The Pathologist

February 16, 2026

How Methodological Flaws Distorted a Decade of Serum SERS Studies

A cautionary tale about spectral interpretation, methodological rigor, and the pressure to publish

The Analytical Scientist

February 16, 2026

Decision Making in the Modern OR: Designing for Efficiency and Predictability

How experienced surgeons balance innovation, consistency, and confidence

The Ophthalmologist

February 13, 2026

Breaking the Biomarker Bottlenecks: Part 1

When pharmaceutical and diagnostic companies collaborate, precision medicine reaches patients faster, say these industry leaders

The Pathologist

February 13, 2026

What Was Promised at Confirmation?

After pledging to uphold vaccine policy and funding, RFK Jr. has reshaped advisory panels, research priorities, and immunization guidance.

KFF Health News

February 09, 2026

Budget Cuts Put Vision Health Progress at Risk, Warns Prevent Blindness

Prevent Blindness responds to Congress’s decision to reduce funding for the CDC’s Vision Health Initiative

The Ophthalmologist

February 06, 2026

When Other People’s Cells Become Our Own

Researchers outline diagnostic hurdles in studying microchimerism and its potential links to health and disease

The Pathologist

February 05, 2026

Can We Keep Diagnostic Autonomy in an AI World?

Amal Asar on smarter teaching sets, digital slide archives, and the future of training at scale

The Pathologist

February 05, 2026

Five Ways AI Will Reshape Life Sciences in 2026

Why people, process, and purpose matter most

The Medicine Maker